Riskpilot← Back to searchSign inGet full accessAttends OY
OYActiveY-tunnus 1526265-2Pb 7330Wholesale of pharmaceutical and medical goods · NACE 4646Est. 1999— employees
Revenue 2025
EUR 4,7M
-4% vs 2024
EBITDA margin
0.5%
-99% vs 2024
Equity ratio
87.0%
Financial strength
Net profit 2025
EUR 39K
-21% vs 2024
| Revenue | EUR 4,7M | -4% |
| EBITDA | EUR 26K | -99% |
| Net profit | EUR 39K | -21% |
| Total assets | EUR 1,5M | +1% |
| Equity | EUR 1,3M | +3% |
| Employees | — | — |
Legal name
Attends OY
Y-tunnus number
1526265-2
Legal form
Osakeyhtiö
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
12. maaliskuuta 1999
Share capital
EUR 8 000
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Hallituksen jäsenet kaksi yhdessä
Company purpose
Bolagets verksamhetsområde är att inom Europa bedriva handel med hjälpmedel i form av engångsartiklar för inkontinens för användning inom hälso- och sjukvård samt därmed förenlig verksamhet.
Address
Pb 7330
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 5 019 | 5 317 | 5 277 | 5 348 | 4 937 | 4 884 | 4 926 | 4 746 |
| Staff expenses | — | — | — | — | — | −0 | −0 | −0 |
| EBITDA | 31 | 34 | 14 | 29 | 38 | 31 | 4 265 | 26 |
| Depreciation & amort. | — | — | — | — | — | −0 | −0 | −0 |
| EBIT | 31 | 34 | 14 | 29 | 38 | 31 | 4 265 | 26 |
| Net financials | 1 | 1 | 171 | 0 | 4 | 1 | 22 | 23 |
| Profit before tax | 32 | 34 | 185 | 29 | 41 | 32 | 179 | 49 |
| Tax | 6 | 7 | 3 | 6 | 8 | −0 | −0 | 10 |
| Net profit | 26 | 28 | 182 | 24 | 33 | 32 | 49 | 39 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 1 315 | 1 558 | 1 814 | 1 470 | 1 394 | 0 | 1 506 | 1 518 |
| Equity | 934 | 962 | 1 144 | 1 167 | 1 200 | 0 | 1 281 | 1 320 |
| Long-term debt | — | — | — | — | — | 0 | 0 | 0 |
| Short-term debt | 381 | 596 | 670 | 303 | 193 | 191 | 231 | 197 |
| Total debt | 381 | 596 | 670 | 303 | 193 | 0 | 225 | 197 |
EBITDA margin
0.5%
This company
15.8%
Market median
-97% vs market
20182025
Equity ratio
87.0%
This company
38.2%
Market median
+128% vs market
20182025
Return on equity
3.0%
This company
18.4%
Market median
-84% vs market
20182025
Net profit margin
0.8%
This company
8.1%
Market median
-90% vs market
20182025
Asset turnover
3.13×
This company
1.12×
Market median
+179% vs market
20182025
Debt / equity
0.15×
This company
0.62×
Market median
+76% vs market
20182025
- Annual report 2025Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via PRH / YTJ · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via PRH / YTJ · Period 2018-01-01 – 2018-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
LL | Audit | 2012 | — | — |
EB Chief Executive Officer | Chief Executive Officer | 1999 | — | — |
TA | Audit | 2021 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairperson | 2018 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2018 | — | — | |
| Board of Directors | 2019 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Attends OY also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Leena Lisette Puumala | Audit | 0 companies |
| Erik Banks | Chief Executive Officer | 0 companies |
| Tiina Annika Puukkoniemi | Audit | 0 companies |
| Mattias Robert Wilner | Chairperson | 0 companies |
| Emilio Barta Pérez | Board of Directors | 0 companies |
| Hans Arne Hjelm | Board of Directors | 0 companies |
| Anna Clara Södergren | Board of Directors | 0 companies |